🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Starting day 2 of scientific presentations SGO! Dr Herzog presents data from GOG 3044 showing no benefit adding Afuresertib to weekly Taxol in plat-resistant recurrent #ovariancancer. #SGOMtg #SGO2025

🙌Azenosertib (WEE1i) has high activity in CCNE1 positive recurrent #ovariancancer - 👏👏👏design trials based on the right science and you get great results!!! Incredible durable response - 34.9% in IHC positive tumors! The GOG Foundation Inc. #gyncsm #SGOMtg #SGO2025

Exciting data by Dr Simpkins from GOG 3066/DENALI study showing activity of Azenosertib in plat-resistant #ovariancancer stratified by cyclin E1 IHC overexpression. ORR 35% in cyclin E1 biomarker positive! #SGOMtg #SGO2025

Dr Rubinstein presenting novel Trop-2 ADC at 3mg/kg dose led to 80% disease control rate in plat-resistant #ovariancancer. Most common toxicity stomatitis which can be managed with early intervention. #SGOMtg #SGO2025

Equity for rural health. Get creative on how to give great care. #Sgomtg #DEI ⁦SGO⁩ ⁦FdtnForWomensCancer⁩

Dr. Herzog presenting The GOG Foundation Inc. PROFECTA-II/GOG-3044 trial of paclitaxel +/- afuresertib for platinum resistant ov cancer. Negative trial, but identified targets! SGO The GOG Foundation Inc. #SGO2025 #SGOMtg

Congratulations ⁦Jude Nawlo⁩ on ⁦evaluating post-EWOC practice patterns in elderly cohort #ovarinacancer pts! Pts w single agent carbo had worst outcomes- impt@to use platinum doublet when feasible. ⁦SGO⁩ ⁦The GOG Foundation Inc.⁩ ⁦IGCS⁩ GYN Cancer | #GYNCSM ⁦

🌟Dr. Maya Gross of Ready Set GYO presenting her data on delays in gyn onc referrals for patients with limited English proficiency. Opportunities to identify those at risk for care delays and increase support! SGO UW Department of Obstetrics & Gynecology UW Dept. of Ob-Gyn

These leaders define how to #MultiplyYourImpact. Great session on leadership beyond the OR and Clinic. ⁦SGO⁩ #SGOMtg #SGO2025

The ultimate Impact Player and Multiplier! ⁦Amanda Nickles Fader, MD⁩ giving the Presidential Address at #SGO2025!

Empowering story from our SGO President Amanda Nickles Fader, MD with personal connection to Seattle and Fred Hutch Cancer Center helping to drive her passion and mission as an expert #leader and #impact player in our field! #SGOMtg #SGO2025

🔥♥️🤩👏Inspiring talk to #MultiplyYourImpact by Amanda Nickles Fader, MD at #SGOMtg #SGO2025 🔥🔥🔥An awesome SGO president in a time of uncertainty!!!

Thank you ⁦Amanda Nickles Fader, MD⁩ for advocating for our field. A time for us to rise as a specialty to advocate for our patients and science. ⁦SGO⁩ ⁦FdtnForWomensCancer⁩ #sgomtg #SGO2025

Thank you Dr. Nickles Fader and Dr. Gardner for your leadership with SGO and FdtnForWomensCancer to unite the efforts of SGO and the FWC under a synergyistic mission to eradicate gyn cancer and train the next generation of providers Amanda Nickles Fader, MD #SGO2025 #SGOMtg

⁦Amanika⁩ decentralized trials: bringing clinical trials to the patients home. Exciting new frontier for modifiable factors to improve patient outcomes. ⁦SGO⁩ ⁦FdtnForWomensCancer⁩ #sgomtg #SGO2025

🔥🔥🔥🔥TUBA-WISP II with amazing enrollment and the start of exciting and interesting data for high risk patients. Thank you Dr. Gootzen and the whole team! ⁦SGO⁩ ⁦FdtnForWomensCancer⁩ #SGOMtg #SGO2025

Menopause education to providers of high risk patients undergoing RR surgery. Improving QOL for patients! ⁦SGO⁩ ⁦FdtnForWomensCancer⁩ #sgomtg

Excellent distillation by Dr. Sisodia on study from Dr. Meyer. We need to measure what matters to patients! ⁦SGO⁩ ⁦FdtnForWomensCancer⁩ #SGOMtg #SGO2025

Thank you Dr. Monica Bertagnolli. Reminder to why we do this: society, patients, colleagues. ⁦SGO⁩ #sgomtg #sgo2025

Key themes from patients for prehabilitation. Excellent work from Mayo team. #sgomtg #sgo2025 ⁦SGO⁩